摘要
从交易费用理论视角看,我国医联体的实质是公立医院公共服务作用和规模边界延伸状态下的公共物品与服务供给机构。但因为医联体在制度设计、利益分配、监管方式、信息互享以及资源共通等方面的不足,其自身又出现了协调、激励、监督、信息和决策等新的交易费用问题。文章在对医联体交易费用问题的产生原因进行分析的基础上,进而寻找应对措施,以期优化医联体发展路径,提升其医疗资源整合效果。
From the perspective of transaction cost theory,the essence of the economics of s*China medical consortia is the public service function of public hospitals and the public goods and service provider in the state of scale boundary extension.However,due to the shortcomings of medical consortia in system design,benefit distribution,supervision mode,information sharing and resource sharing,it has new transaction cost problems such as coordination,incentive,supervision,information and decision-making.On the basis of exploring the problems caused by transaction cost,it demonstrates and analyzes the causes and countermeasures of the transaction cost of medical consortia,in order to optimize the development path of medical consortia and improve the effect of medical resource integration.
作者
姜锡明
梁若浩
JIANG Xi-ming;LIANG Ruo-hao(Xinjiang University of Finance&Economics,Urumqi,830001,China)
出处
《中国卫生经济》
北大核心
2020年第2期26-29,共4页
Chinese Health Economics
基金
国家自然科学基金项目(71662033)。
关键词
交易费用
医疗联合体建设
整合医疗资源
transaction costs
medical alliance construction
medical resource integration